Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05929664
Title Cemiplimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Jefferson University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Thomas Jefferson University Hospital RECRUITING Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field